3,277
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Vision impairment is common in non-hospitalised patients with post-COVID-19 syndrome

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 324-331 | Received 16 Feb 2023, Accepted 09 May 2023, Published online: 18 May 2023

References

  • Luo X, Lv M, Zhang X et al. Clinical manifestations of COVID-19: an overview of 102 systematic reviews with evidence mapping. J Evid Based Med 2022; 15: 201–215. doi:10.1111/jebm.12483.
  • Sen M, Honavar SG, Sharma N et al. COVID-19 and Eye: a review of ophthalmic manifestations of COVID-19. Indian J Ophthalmol 2021; 69: 488–509. doi:10.4103/ijo.IJO_297_21.
  • Forouhari A, Mansouri V, Safi S et al. A systematic literature review and bibliometric analysis of ophthalmology and COVID-19 research. J Ophthalmol 2022; 2022: 8195228. doi:10.1155/2022/8195228.
  • Petzold A. Neuro-ophthalmic implications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) related infection and vaccination. Asia Pac J Ophthalmol (Phila) 2022; 11: 196–207. doi:10.1097/APO.0000000000000519.
  • Tisdale AK, Dinkin M, Chwalisz BK. Afferent and efferent neuro-ophthalmic complications of coronavirus disease 19. J Neuroophthalmol 2021; 41: 154–165. doi:10.1097/WNO.0000000000001276.
  • Teo KY, Invernizzi A, Staurenghi G et al. COVID-19 related retinal micro-vasculopathy - a review of current evidence: COVID-19 related retinal micro-vasculopathy. Am J Ophthalmol 2021; 235: 98–110. doi:10.1016/j.ajo.2021.09.019.
  • Divanoglou A, Samuelsson APK, Sjodahl PER et al. Rehabilitation needs and mortality associated with the Covid-19 pandemic: a population-based study of all hospitalised and home-healthcare individuals in a Swedish healthcare region. EClinicalMedicine 2021; 36: 100920. doi:10.1016/j.eclinm.2021.100920.
  • Johansson J, Levi R, Jakobsson M et al. Multi-professional neurorehabilitation after Covid-19 infection should include assessment of visual function. Arch Rehabil Res Clin Transl 2022; 4 : 100184. doi:10.1016/j.arrct.2022.100184.
  • Bronstein AM. The visual vertigo syndrome. Acta Otolaryngol Suppl 1995; 520 Pt : 45–48. doi:10.3109/00016489509125186.
  • Bednarczuk NF, Bonsu A, Ortega MC et al. Abnormal visuo-vestibular interactions in vestibular migraine: a cross sectional study. Brain 2019; 142: 606–616. doi:10.1093/brain/awy355.
  • Winkler PA, Ciuffreda KJ. Ocular fixation, vestibular dysfunction, and visual motion hypersensitivity. Optometry 2009; 80: 502–512. doi:10.1016/j.optm.2009.01.014.
  • Kelly KM, Anghinah R, Kullmann A et al. Oculomotor, vestibular, reaction time, and cognitive tests as objective measures of neural deficits in patients post COVID-19 infection. Front Neurol 2022; 13: 919596. doi:10.3389/fneur.2022.919596.
  • Ballering AV, van Zon SKR, Olde Hartman TC et al. Lifelines corona research I. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet 2022; 400: 452–461. doi:10.1016/S0140-6736(22)01214-4.
  • Townsend L, Dyer AH, Jones K et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLos One 2020; 15 : e0240784. doi:10.1371/journal.pone.0240784.
  • Holdsworth DA, Chamley R, Barker-Davies R et al. Comprehensive clinical assessment identifies specific neurocognitive deficits in working-age patients with long-COVID. PLos One 2022; 17 : e0267392. doi:10.1371/journal.pone.0267392.
  • Tavares-Junior JWL, de Souza ACC, Borges JWP et al. COVID-19 associated cognitive impairment: a systematic review. Cortex 2022; 152: 77–97. doi:10.1016/j.cortex.2022.04.006.
  • Laukkanen H, Scheiman M, Hayes JR. Brain injury vision symptom survey (BIVSS) questionnaire. Optom Vis Sci 2017; 94: 43–50. doi:10.1097/OPX.0000000000000940.
  • Rouse MW, Borsting EJ, Mitchell GL et al. Validity and reliability of the revised convergence insufficiency symptom survey in adults. Ophthalmic Physiol Opt 2004; 24: 384–390. doi:10.1111/j.1475-1313.2004.00202.x.
  • Garzia RP, Richman JE, Nicholson SB et al. A new visual-verbal saccade test: the development eye movement test (DEM). J Am Optom Assoc 1990; 61: 124–135.
  • Tannen B, Bagavandoss S, Ciuffreda KJ et al. Clinical quantitative assessment of visual motion sensitivity in concussion/mild traumatic brain injury. Vis Dev Rehabil 2020; 6: 264–268.
  • Moller MC, Johansson J, Matuseviciene G et al. An observational study of trait and state fatigue, and their relation to cognitive fatigability and saccade performance. Concussion 2019; 4 : CNC62. doi:10.2217/cnc-2019-0003.
  • Kerkhoff G. Neurovisual rehabilitation: recent developments and future directions. J Neurol Neurosurg Psychiatry 2000; 68: 691–706. doi:10.1136/jnnp.68.6.691.
  • Pitzalis S, Fattori P, Galletti C. The human cortical areas V6 and V6A. Vis Neurosci 2015; 32: E007. doi:10.1017/S0952523815000048.
  • Gervasoni F, LoMauro A, Ricci V et al. Balance and visual reliance in post-COVID syndrome patients assessed with a robotic system: a multi-sensory integration deficit. Neurol Sci 2022; 43: 85–88. doi:10.1007/s10072-021-05647-8.
  • Gambini G, Savastano MC, Savastano A et al. Ocular surface impairment after COVID-19: a cohort study. Cornea 2021; 40: 477–483. doi:10.1097/ICO.0000000000002643.
  • McHarg M, Wang Y, Yakin M et al. Ocular symptoms in COVID-19 infection: a survey study. J Ophthalmic Inflamm Infect 2022; 12: 42. doi:10.1186/s12348-022-00319-w.
  • Hellgren L, Levi R, Divanoglou A et al. Seven domains of persisting problems after hospital-treated Covid-19 indicate a need for a multiprofessional rehabilitation approach. J Rehabil Med 2022; 54: jrm00301. doi:10.2340/jrm.v54.2434.
  • Moghimi N, Di Napoli M, Biller J et al. The neurological manifestations of post-acute sequelae of SARS-CoV-2 infection. Curr Neurol Neurosci Rep 2021; 21: 44. doi:10.1007/s11910-021-01130-1.
  • Diel RJ, Mehra D, Kardon R et al. Photophobia: shared pathophysiology underlying dry eye disease, migraine and traumatic brain injury leading to central neuroplasticity of the trigeminothalamic pathway. Br J Ophthalmol 2021; 105: 751–760. doi:10.1136/bjophthalmol-2020-316417.
  • Buchanan TM, Digre KB, Warner JEA et al. The unmet challenge of diagnosing and treating photophobia. J Neuroophthalmol 2022; 42: 372–377. doi:10.1097/WNO.0000000000001556.
  • Chang TT, Ciuffreda KJ, Kapoor N. Critical flicker frequency and related symptoms in mild traumatic brain injury. Brain Inj 2007; 21: 1055–1062. doi:10.1080/02699050701591437.
  • Katz BJ, Digre KB. Diagnosis, pathophysiology, and treatment of photophobia. Surv Ophthalmol 2016; 61: 466–477. doi:10.1016/j.survophthal.2016.02.001.